Cargando…
Complement-targeted therapies in kidney transplantation—insights from preclinical studies
Aberrant activation of the complement system contributes to solid-organ graft dysfunction and failure. In kidney transplantation, the complement system is implicated in the pathogenesis of antibody- and cell-mediated rejection, ischemia-reperfusion injury, and vascular injury. This has led to the ev...
Autores principales: | Anwar, Imran J., DeLaura, Isabel, Ladowski, Joseph, Gao, Qimeng, Knechtle, Stuart J., Kwun, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606228/ https://www.ncbi.nlm.nih.gov/pubmed/36311730 http://dx.doi.org/10.3389/fimmu.2022.984090 |
Ejemplares similares
-
Harnessing the B Cell Response in Kidney Transplantation – Current State and Future Directions
por: Anwar, Imran J., et al.
Publicado: (2022) -
Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery
por: Delaura, Isabel F., et al.
Publicado: (2022) -
Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant
por: Manook, Miriam, et al.
Publicado: (2023) -
Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?
por: Gao, Qimeng, et al.
Publicado: (2022) -
Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: Schroder, Paul M., et al.
Publicado: (2017)